1488-P: HbA1c and Potential Misclassification of Diabetes and Prediabetes Diagnoses in the U.S.
Lisa R. Staimez(Emory University), Lawrence S. Phillips(University at Buffalo, State University of New York), Lauren M. Kipling(Emory University), J. Nina Ham(Emory University), Mary K. Rhee(Atlanta VA Health Care System), Christopher N. Ford(Emory University)
Cited by 0
Related Papers
Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer
|New England Journal of Medicine|2006|985
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
Vitamin D Supplementation and Prevention of Type 2 Diabetes
|New England Journal of Medicine|2019|662
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
|The Lancet|2001|643
Use of Thiazolidinediones and Risk of Heart Failure in People With Type 2 Diabetes
|Diabetes Care|2003|216